Thursday broker round-up UPDATE
30th May 2013 08:19
AMEC: Morgan Stanley reduces target price from 1220p to 1100p and retains an underweight rating. Amlin: JP Morgan takes target price from 360p to 400p maintaining an underweight rating. Brewin Dolphin: Canaccord Genuity raises target price from 230p to 285p and reiterates a buy recommendation. C
Read moreWednesday tips round-up: Sirius Minerals, Volex, GlaxoSmithKline
29th May 2013 06:54
The global pharmaceuticals sector is stuck in the 'doldrums' due to the impact of the so-called 'patent-cliff.' However, they have rebounded from their previous cycle lows - even in the case of laggards such as AstraZeneca, GlaxoSmithKline or Novartis - as investors seem to appreciate their defensiv
Read moreLondon close: Stimulus hopes drive triple-digit gains for FTSE 100
28th May 2013 16:49
While hopes have now faded for a long-term continuation of stimulus measures in the US, speculation surrounding continued monetary easing in Europe and Japan sparked a huge surge on equity markets on Tuesday. After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter par
Read moreLondon midday: Stocks bounce back after recent sell-off
28th May 2013 11:20
UK markets were registering impressive gains on Tuesday morning with hopes of continued monetary easing in the Eurozone lifting sentiment as stocks bounced back following last week's sharp sell-off. After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last
Read moreLondon open: Stocks surge as markets play catch up after long weekend
28th May 2013 08:30
UK markets surged in early trading on Tuesday with traders wasting no time in playing catch up as they returned to their desks following the three-day weekend. After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last week on fears of a scaling back of stim
Read moreTuesday broker round-up UPDATE
28th May 2013 07:25
AG Barr: Investec increases target price from 562p to 591p, while downgrading from buy to add. Canaccord Genuity downgrades to hold with a target price of 570p. Amara Mining: Cantor Fitzgerald cuts target price from 81p to 63p and retains a buy recommendation. Compass Group: Nomura ups target pric
Read moreWednesday broker round-up UPDATE
22nd May 2013 09:37
Afferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation. Amara Mining: Westhouse Securities cuts target price from 110p to 90p retaining a buy recommendation. Amlin: Westhouse Securities moves target price from 455p to 470p and upgrades to add.
Read moreGlaxo hit by US regulatory delay
1st May 2013 12:42
GlaxoSmithKline has been hit by a delay to one of the six key drugs on which it was awaiting regulatory decisions this year. The US Food and Drug Administration (FDA) moved the date when it will votes on whether to approve or reject GSK's experimental cancer drug Trametinib back to September 3rd 2
Read moreGlaxoSmithKline submits application for COPD drug in EU
26th Apr 2013 10:46
GlaxoSmithKline (GSK) has submitted a regulatory application in the EU for umeclidinium monotherapy, an investigative once-daily medicine used in patients with chrinic obstructive pulmonary disease (COPD). The treatment, which is administered using the company's Ellipta inhaler, is designed to rel
Read moreGSK advances on plans to sell Lucozade and Ribena brands, Q1 results disappoint
24th Apr 2013 12:11
FTSE 100-listed pharmaceuticals group GlaxoSmithKline (GSK) has announced plans to sell its Lucozade and Ribena brands during its less-than-impressive first quarter results, which showed a two per cent contraction in group sales. Some analysts have suggested that the decision to sell the brands cou
Read moreMonday broker round-up UPDATE
22nd Apr 2013 07:20
Admiral Group: Deutsche Bank takes target price from 1140p to 1300p retaining a hold recommendation. African Barrick Gold: Deutsche Bank ups target price from 173p to 180p staying with its hold recommendation. Albemarle & Bond: Canaccord Genuity reduces target price from 280p to 146p and downgrade
Read moreLondon close: ENRC and miners give markets a boost
19th Apr 2013 16:33
London's stock markets ended the week on a positive note, finishing with decent gains following a five-day losing streak, with mining stocks doing their best to recover after the recent sell-off. ENRC was a standout performer in the sector, surging by over a quarter by the close on the back of repo
Read moreFTSE 100 movers: ENRC rockets on possible takeover plans
19th Apr 2013 16:01
Mining stocks were performing well as investors sought gains after a volatile week for the sector. Vedanta, EVRAZ and Fresnillo were all making decent gains by mid-afternoon. ENRC shares surged Friday after major shareholder Alexander Machkevitch said he was considering a takeover bid for the Kaza
Read moreLondon midday: Mining rebound lifts markets higher
19th Apr 2013 11:57
The FTSE 100 rebound on Friday morning after a five-day losing streak as strong gains in the mining sector lifted London's benchmark higher. "Clients who went bargain hunting in the mining space after the aggressive sell-off earlier in the week have been rewarded this morning, as the sector bounces
Read moreGlaxoSmithKline accused of paying off competitors
19th Apr 2013 11:10
GlaxoSmithKline (GSK) is being investigated over claims it paid off firms to delay the launch of cheap versions of its anti-depression drug, according to reports Friday. The UK's Office of Fair Trading (OFT) said GSK offered payments to Alpharma, Generics and Norton Healthcare, to postpone the rele
Read more